Long-term use of methylnaltrexone for the management of constipation in advanced cancer.
Dutka
Jennifer
J
Department of Symptom Control and Palliative Care, Cross Cancer Institute, Edmonton, Alberta, Canada.
Lowe
Sonya S
SS
Michaud
Mary
M
Watanabe
Sharon
S
D000328:Adult; D001254:Astrocytoma / Q000473:pathology* / Q000601:surgery; D003248:Constipation / Q000139:chemically induced / Q000188:drug therapy*; D006801:Humans; D008175:Lung Neoplasms / Q000473:pathology*; D008297:Male; D008479:Mediastinal Neoplasms / Q000473:pathology*; D008875:Middle Aged; D009271:Naltrexone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D009292:Narcotic Antagonists / Q000627:therapeutic use*; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D055752:Small Cell Lung Carcinoma / Q000473:pathology*; D015996:Survival Rate; D016896:Treatment Outcome
D009292:Narcotic Antagonists; D000644:Quaternary Ammonium Compounds; C032257:methylnaltrexone; D009271:Naltrexone